EUVIMEDEUVIMED entdecken
Crossref

Redefining Available Therapy in Oncology Accelerated Approval Decisions

Shruti Rajesh Patel iD, Maya Ramachandran, Angela Ai, Christopher T Chen iD

Journal of Clinical Oncology · 2025

DOI: 10.1200/jco.24.00892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2025. Verfasst von Shruti Rajesh Patel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA. Hauptthemen laut MEDLINE: Drug Approval, Neoplasms, Medical Oncology, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When weighing rapid approval for follow-on drugs, should @FDAOncology recognize the drugs that came before?

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ApprovalNeoplasmsMedical OncologyAntineoplastic AgentsHumansUnited States Food and Drug AdministrationUnited States

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Department of Internal Medicine, UCLA-Olive View, Sylmar, CA.

ORCID-Profile: Shruti Rajesh Patel, Christopher T Chen

Zitieren

APA

Patel, S. R., Ramachandran, M., Ai, A., & Chen, C. T. (2025). Redefining Available Therapy in Oncology Accelerated Approval Decisions. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00892

Vancouver

Patel SR, Ramachandran M, Ai A, Chen CT. Redefining Available Therapy in Oncology Accelerated Approval Decisions. Journal of Clinical Oncology. 2025. doi:10.1200/jco.24.00892

BibTeX
@article{Patel2025,
  author = {Patel, Shruti Rajesh and Ramachandran, Maya and Ai, Angela and Chen, Christopher T},
  title = {Redefining Available Therapy in Oncology Accelerated Approval Decisions},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1200/jco.24.00892}
}
Kostenlos starten →